The College’s Jurisprudence Exam Modernization Project (JEMP) is now complete. After initial postponement due to the COVID-19 pandemic, the JEMP started in March 2021, and the exam development process was completed in April 2022.
At it’s April 2022 meeting, the College Board approved amendments to the Pharmacy Operations and Drug Scheduling Act (PODSA) and the Health Professions Act (HPA) to adopt the National Association of Pharmacy Regulatory Authorities (NAPRA) model standards for sterile compounding as the updated College Standards for Sterile Compounding.
The College Standards for Sterile Compounding will come into effect on July 4, 2022.
Dismantling Indigenous Specific Racism: One Year Progress Report from BC’s Largest Health Regulators
In May 2021, the College of Pharmacists of BC, the College of Physicians and Surgeons of BC, the BC College of Nurses and Midwives, and the College of Dental Surgeons of BC, issued an apology to Indigenous peoples and communities in BC for the racism and discrimination they have experienced while engaging with us and with the health professionals we regulate.
The College's practice support services team provides phone and email assistance to pharmacy registrants or other stakeholders who have questions related to the application of legislation or pharmacy practice standards.
B.C. PharmaCare medication review services are delivered by community pharmacists to help patients understand and manage their medications, and to identify and resolve drug therapy problems. The service is available to all B.C. residents who meet eligibility criteria.
PharmaCare has created a consolidated list of fully covered First Nations Health Benefits (Plan W) over-the-counter (OTC) drugs. The online OTC list provides a simple, sortable reference tool to help healthcare providers, health advocates, and patients navigate Plan W and understand which OTC items are eligible benefits.
Accurate record-keeping in PharmaNet is important for ensuring patient safety by making patient information available to healthcare providers across different settings.
This article will review some areas of non-compliance that Compliance Officers have observed regarding PharmaNet record-keeping, while conducting Practice Reviews.
On March 31, 2022, tramadol was removed from the Prescription Drug List (PDL) and listed in Schedule I of the Controlled Drugs and Substances Act (CDSA). It was also listed as item 19 in the Schedule of the Narcotic Control Regulations (NCR). Therefore, tramadol is now subject to all the regulatory requirements set out in the CDSA and NCR.
Since March 31, the College has received a number of questions from registrants on the implications of this change on their practice. This article explores and provides clarity on some of the most common questions received by College staff.
Nirmatrelvir/ritonavir (Paxlovid™) is an oral antiviral drug used to treat mild-to-moderate COVID-19 in adults who do not require hospitalization and are at high risk of progressing to serious illness.
This year UBC’s Continuing Pharmacy Professional Development (CPPD) celebrates its 33rd annual Update Conference. The UBC Faculty of Pharmaceutical Sciences will offer this program virtually.